Download PDF
Dtsch Med Wochenschr 2006; 131(16): 909-919
DOI: 10.1055/s-2006-939868
CME-Beitrag | Review article
Gastroenterologie
© Georg Thieme Verlag KG Stuttgart · New York

Gastroösophageale Refluxkrankheit

Gastroesophageal reflux diseaseJ. Labenz1 , D.-P Borkenstein1 , A. Leodolter1 , J. F. Riemann2
  • 1Medizinische Klinik, Ev. Jung-Stilling-Krankenhaus Siegen
  • 2Medizinische Klinik C, Klinikum Ludwigshafen
Further Information

Publication History

eingereicht: 23.1.2006

akzeptiert: 16.3.2006

Publication Date:
20 April 2006 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Gastroösophageale Refluxkrankheit - nicht-erosive Refluxkrankheit - erosive Refluxkrankheit - Barrett-Ösophagus

Key words

gastro-oesophageal reflux disease - non-erosive reflux disease - erosive reflux disease - Barrett's oesophagus

Literatur

  • 1 Adamek R, Wienbeck M. Ösophageale Motilitätsprofile bei gastroösophagealem Reflux - Konsequenzen für die Therapie.  Leber Magen Darm. 1998;  28 245-248
    Google Scholar
  • 2 Arguedas M R, Heudebert G R, Klapow J C. et al . Re-examination of the cost-effectiveness of surgical versus medical therapy in patients with gastroesophageal reflux disease: the value of long-term data collection.  Am J Gastroenterol. 2004;  99 1023-1028
    Google Scholar
  • 3 Armstrong D. Review article: towards consistency in the endoscopic diagnosis of BarrettŽs oesophagus and columnar metaplasia.  Aliment Pharmacol Ther. 2004;  20 (Suppl 5) 40-47
    Google Scholar
  • 4 Bell N J, Burget D, Howden C W, Wilkinson J, Hunt R H. Appropriate acid suppression for the management of gastro-oesophageal reflux disease.  Digestion. 1992;  51 (Suppl 1) 59-67
    Google Scholar
  • 5 Borjesson M, Rolny P, Mannheimer C. et al . Nutcracker esophagus: a double-blind, placebo-controlled, cross-over study of the effects of lansoprazole.  Aliment Pharmacol Ther. 2003;  18 1129-1135
    Google Scholar
  • 6 Chiba N, De Gara C J, Wilkinson J M, Hunt R H. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.  Gastroenterology. 1997;  112 1798-1810
    Google Scholar
  • 7 Chrysos E, Athanasakis E, Zoras O J. et al . Twenty-four-hour ambulatory versus stationary esophageal manometry in the evaluation of esophageal motility in patients with gastroesophageal reflux disease.  Digestion. 2002;  66 1-8
    Google Scholar
  • 8 Corley D A, Katz P, Wo J M. et al . Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial.  Gastroenterology. 2003;  125 668-676
    Google Scholar
  • 9 Cremonini F, Wise J, Moayyedi P, Talley N J. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: metaanalysis.  Am J Gastroenterol. 2005;  100 1226-1232
    Google Scholar
  • 10 Dean B B, Gano A D, Knight K. et al . Effectiveness of proton pump inhibitors in nonerosive reflux disease.  Clin Gastroenterol Hepatol. 2004;  2 656-664
    Google Scholar
  • 11 DeVault K R, Castell D O. American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.  Am J Gastroenterol. 2005;  100 190-200
    Google Scholar
  • 12 Devière J, Costamagna G, Neuhaus H. et al . Nonresorbable copolymer implantation for gastroesophageal reflux disease: a randomized sham-controlled multicenter trial.  Gastroenterology. 2005;  128 532-540
    Google Scholar
  • 13 Fackler W K, Ours T M, Vaezi M F, Richter J E. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.  Gastroenterology. 2002;  122 625-632
    Google Scholar
  • 14 Fang J. Nutcracker esophagus: GERD or an esophageal motility disorder.  Am J Gastroenterol. 2002;  97 1556-1557
    Google Scholar
  • 15 Fass R, Ofman J J. Gastroesophageal reflux disease - should we adopt a new conceptual framework?.  Am J Gastroenterol. 2002;  97 1901-1907
    Google Scholar
  • 16 Guda N, Partington S, Vakil N. Symptomatic gastro-oesophageal reflux, arousals and sleep quality in patients undergoing polysomnography for possible obstructive sleep apnoea.  Aliment Pharmacol Ther. 2004;  20 1153-1159
    Google Scholar
  • 17 Hansen A N, Bergheim R, Fagertun H, Lund H, Moum B. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.  Int J Clin Pract. 2005;  59 665-671
    Google Scholar
  • 18 Hansen A N, Wahlqvist P, Jorgensen E. et al . Six-month management of patients following treatment for gastroesophageal reflux disease symptoms - a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.  Int J Clin Pract. 2005;  59 655-664
    Google Scholar
  • 19 Howden C W, Henning J M, Huang B, Lukasik N, Freston J W. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.  Am J Gastroenterol. 2001;  96 1704-1710
    Google Scholar
  • 20 Johnson D A, Orr W C, Crawley J A. et al . Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebo-controlled trial.  Am J Gastroenterol. 2005;  100 1914-1922
    Google Scholar
  • 21 Koop H, Schepp W, Muller-Lissner S. et al . Gastroösophageale Refluxkrankheit - Ergebnisse einer evidenzbasierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten.  Z Gastroenterol. 2005;  43 163-194
    Google Scholar
  • 22 Kulig M, Nocon M, Vieth M. et al . Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.  J Clin Epidemiol. 2004;  57 580-589
    Google Scholar
  • 23 Labenz J, Borkenstein D P. Pathophysiologie und Diagnostik der Refluxkrankheit.  Internist. 2003;  44 11-20
    Google Scholar
  • 24 Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease.  World J Gastroenterol. 2005;  11 4291-4299
    Google Scholar
  • 25 Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.  N Engl J Med. 1999;  340 825-831
    Google Scholar
  • 26 Martinez S D, Malagon I B, Garewal H S, Cui H, Fass R. Non-erosive reflux disease (NERD) - acid reflux and symptom patterns.  Aliment Pharmacol Ther. 2003;  17 537-545
    Google Scholar
  • 27 Meining A, Classen M. The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease.  Am J Gastroenterol. 2000;  95 2692-2697
    Google Scholar
  • 28 Morse C A, Quan S F, Mays M Z. et al . Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease?.  Clin Gastroenterol Hepatol. 2004;  2 761-768
    Google Scholar
  • 29 Numans M E, Lau J, de Wit N J, Bonis P A. Short-term treatment with proton pump inhibitors as a test for gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics.  Ann Intern Med. 2004;  140 518-527
    Google Scholar
  • 30 Richter J E. Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease.  Aliment Pharmacol Ther. 2005;  22 (Suppl 1) 70-80
    Google Scholar
  • 31 Shaheen N J. Advances in BarrettŽs esophagus and esophageal adenocarcinoma.  Gastroenterology. 2005;  128 1544-1566
    Google Scholar
  • 32 Shaw M. Diagnostic utility of reflux disease symptoms.  Gut. 2004;  53 (Suppl IV) 28-34
    Google Scholar
  • 33 Sjöstedt S, Befrits R, Sylvan A. et al . Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis.  Aliment Pharmacol Ther. 2005;  22 183-191
    Google Scholar
  • 34 Tsai H H, Chapman R, Shepherd A. et al . Esomeprazole 20 mg on-demand is more acceptable to patients than continous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND study.  Aliment Pharmacol Ther. 2004;  20 657-665
    Google Scholar
  • 35 Watson R G, Tham T C, Johnston B T, McDougall N I. Double blind cross-over study of omeprazole in the treatment of patients with symptoms and physiological levels of acid reflux - the „sensitive oesophagus”.  Gut. 1997;  40 587-590
    Google Scholar

Prof. Dr. med. J. Labenz

Medizinische Fakultät der Universität Duisburg-Essen, Medizinische Klinik, Ev. Jung-Stilling-Krankenhaus

Wichernstraße 40

57074 Siegen

Phone: 0271/3334569

Fax: 0271/3334242

Email: J.Labenz@t-online.de

      >